Group 1 - The potential de facto legalization of marijuana in the U.S. has gained momentum, positively impacting cannabis stocks like Tilray Brands, which saw an increase of over 8% in price [1] - Republican senators, traditionally resistant to marijuana law reform, have expressed cautious support for decriminalizing the drug, indicating a shift in political sentiment [2][6] - Senator Lisa Murkowski described the proposed rescheduling of marijuana from Schedule I to Schedule III as a "game changer," while Senator Kevin Cramer showed openness to the idea but emphasized a cautious, incremental approach [3] Group 2 - The current state of the marijuana industry is characterized by a patchwork of legalization, with public opinion favoring reform measures such as rescheduling, and influential politicians beginning to support these changes [4] - Investors in Tilray and similar companies are responding positively to the momentum towards legalization and reform in the cannabis sector [4]

Group 1 - A coalition of 32 attorneys general from various U.S. states and territories is advocating for the passage of a marijuana banking bill to reform current banking laws affecting cannabis businesses [2][5] - The proposed SAFER Banking Act aims to provide cannabis businesses with access to essential financial services, which they currently lack due to federal illegality, forcing many to operate on a cash-only basis and increasing crime risks [4] - The bipartisan support for marijuana legalization is reflected in the diverse backgrounds of the attorneys general, indicating broad public support for reform [5] Group 2 - Curaleaf's stock experienced a significant increase of 13% in response to the renewed political push for marijuana banking reform, contrasting with the S&P 500's modest gain of 0.4% [1] - The ongoing pressure for change in marijuana banking laws is viewed positively for the cannabis industry, despite the slow progress in Congressional reform efforts [6]